Pfizer Inc.

NYS: PFE

GO
/marketstate/country/us

Market open

 --Real time quotes

May 7, 2021, 12:27 p.m.

PFE
/zigman2/quotes/202877789/composite

$

39.18

Change

-0.02 -0.04%

Volume

Volume 16.70m

Real time quotes

/zigman2/quotes/202877789/composite

Previous close

$ 39.19

$ 39.18

Change

-0.02 -0.04%

Day low

Day high

$39.05

$39.87

Open

52 week low

52 week high

$29.94

$43.08

Open

Insider Actions for Pfizer Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/27/2021 Frank A. D'Amelio
Executive Vice President
96,872   Derivative/Non-derivative trans. at $34.64 per share. 3,355,646
02/27/2021 Frank A. D'Amelio
Executive Vice President
27,381   Derivative/Non-derivative trans. at $33.49 per share. 916,989
02/27/2021 John D. Young
Group President
82,057   Derivative/Non-derivative trans. at $34.64 per share. 2,842,454
02/27/2021 John D. Young
Group President
23,194   Derivative/Non-derivative trans. at $33.49 per share. 776,767
02/27/2021 Alexander Roderick MacKenzie
Executive Vice President
18,919   Derivative/Non-derivative trans. at $34.64 per share. 655,354
02/27/2021 Alexander Roderick MacKenzie
Executive Vice President
5,812   Derivative/Non-derivative trans. at $33.49 per share. 194,643
02/27/2021 Mikael Dolsten
President R&D
23,841   Derivative/Non-derivative trans. at $33.49 per share. 798,435
02/27/2021 Sally Susman
Executive Vice President
45,587   Derivative/Non-derivative trans. at $34.64 per share. 1,579,133
02/27/2021 Sally Susman
Executive Vice President
14,004   Derivative/Non-derivative trans. at $33.49 per share. 468,993
02/27/2021 Albert Bourla
Chairman & CEO; Director
34,191   Derivative/Non-derivative trans. at $34.64 per share. 1,184,376
02/27/2021 Albert Bourla
Chairman & CEO; Director
9,664   Derivative/Non-derivative trans. at $33.49 per share. 323,647
02/27/2021 Douglas M. Lankler
Executive Vice President
34,191   Derivative/Non-derivative trans. at $34.64 per share. 1,184,376
02/27/2021 Douglas M. Lankler
Executive Vice President
9,664   Derivative/Non-derivative trans. at $33.49 per share. 323,647
02/27/2021 Rady A. Johnson
Executive Vice President
15,955   Derivative/Non-derivative trans. at $34.64 per share. 552,681
02/27/2021 Rady A. Johnson
Executive Vice President
4,510   Derivative/Non-derivative trans. at $33.49 per share. 151,039
02/27/2021 Angela Hwang
Group President
6,268   Derivative/Non-derivative trans. at $34.64 per share. 217,123
02/27/2021 Angela Hwang
Group President
1,772   Derivative/Non-derivative trans. at $33.49 per share. 59,344
02/27/2021 William R. Carapezzi
Executive Vice President
13,676   Derivative/Non-derivative trans. at $34.64 per share. 473,736
02/27/2021 William R. Carapezzi
Executive Vice President
2,985   Derivative/Non-derivative trans. at $33.49 per share. 99,967
02/27/2021 Jennifer B. Damico
SVP & Controller
6,268   Derivative/Non-derivative trans. at $34.64 per share. 217,123
02/27/2021 Jennifer B. Damico
SVP & Controller
1,229   Derivative/Non-derivative trans. at $33.49 per share. 41,159
02/27/2021 Frank A. D'Amelio
Executive Vice President
152,785   Derivative/Non-derivative trans. at $22.35 per share. 3,414,744
02/27/2021 John D. Young
Group President
129,419   Derivative/Non-derivative trans. at $22.35 per share. 2,892,514
02/27/2021 Alexander Roderick MacKenzie
Executive Vice President
29,838   Derivative/Non-derivative trans. at $22.35 per share. 666,879
02/27/2021 Sally Susman
Executive Vice President
71,899   Derivative/Non-derivative trans. at $22.35 per share. 1,606,942
02/27/2021 Albert Bourla
Chairman & CEO; Director
53,925   Derivative/Non-derivative trans. at $22.35 per share. 1,205,223
02/27/2021 Douglas M. Lankler
Executive Vice President
53,925   Derivative/Non-derivative trans. at $22.35 per share. 1,205,223
02/27/2021 Rady A. Johnson
Executive Vice President
25,165   Derivative/Non-derivative trans. at $22.35 per share. 562,437
02/27/2021 Angela Hwang
Group President
9,886   Derivative/Non-derivative trans. at $22.35 per share. 220,952
02/27/2021 William R. Carapezzi
Executive Vice President
21,570   Derivative/Non-derivative trans. at $22.35 per share. 482,089
02/27/2021 Jennifer B. Damico
SVP & Controller
9,886   Derivative/Non-derivative trans. at $22.35 per share. 220,952
02/25/2021 Frank A. D'Amelio
Executive Vice President
105,707   Derivative/Non-derivative trans. at $34.76 per share. 3,674,375
02/25/2021 Frank A. D'Amelio
Executive Vice President
28,221   Derivative/Non-derivative trans. at $33.82 per share. 954,434
02/25/2021 John D. Young
Group President
105,707   Derivative/Non-derivative trans. at $34.76 per share. 3,674,375
02/25/2021 John D. Young
Group President
28,221   Derivative/Non-derivative trans. at $33.82 per share. 954,434
02/25/2021 Alexander Roderick MacKenzie
Executive Vice President
14,227   Derivative/Non-derivative trans. at $33.82 per share. 481,157
02/25/2021 Mikael Dolsten
President R&D
28,271   Derivative/Non-derivative trans. at $33.82 per share. 956,125
02/25/2021 Mikael Dolsten
President R&D
28,271   Derivative/Non-derivative trans. at $33.82 per share. 956,125
02/25/2021 Sally Susman
Executive Vice President
52,853   Derivative/Non-derivative trans. at $34.76 per share. 1,837,170
02/25/2021 Sally Susman
Executive Vice President
15,335   Derivative/Non-derivative trans. at $33.82 per share. 518,629
02/25/2021 Albert Bourla
Chairman & CEO; Director
105,707   Derivative/Non-derivative trans. at $34.76 per share. 3,674,375
02/25/2021 Albert Bourla
Chairman & CEO; Director
28,221   Derivative/Non-derivative trans. at $33.82 per share. 954,434
02/25/2021 Douglas M. Lankler
Executive Vice President
64,599   Derivative/Non-derivative trans. at $34.76 per share. 2,245,461
02/25/2021 Douglas M. Lankler
Executive Vice President
17,246   Derivative/Non-derivative trans. at $33.82 per share. 583,259
02/25/2021 Rady A. Johnson
Executive Vice President
24,371   Derivative/Non-derivative trans. at $34.76 per share. 847,135
02/25/2021 Rady A. Johnson
Executive Vice President
6,422   Derivative/Non-derivative trans. at $33.82 per share. 217,192
02/25/2021 Angela Hwang
Group President
14,682   Derivative/Non-derivative trans. at $34.76 per share. 510,346
02/25/2021 Angela Hwang
Group President
3,920   Derivative/Non-derivative trans. at $33.82 per share. 132,574
02/25/2021 William R. Carapezzi
Executive Vice President
17,618   Derivative/Non-derivative trans. at $34.76 per share. 612,401
02/25/2021 William R. Carapezzi
Executive Vice President
2,983   Derivative/Non-derivative trans. at $33.82 per share. 100,885
02/25/2021 Payal Sahni
Executive Vice President
6,460   Derivative/Non-derivative trans. at $34.76 per share. 224,549
02/25/2021 Payal Sahni
Executive Vice President
1,197   Derivative/Non-derivative trans. at $33.82 per share. 40,482
02/25/2021 Jennifer B. Damico
SVP & Controller
8,075   Derivative/Non-derivative trans. at $34.76 per share. 280,687
02/25/2021 Jennifer B. Damico
SVP & Controller
1,496   Derivative/Non-derivative trans. at $33.82 per share. 50,594
02/25/2021 Frank A. D'Amelio
Executive Vice President
163,334   Derivative/Non-derivative trans. at $22.89 per share. 3,738,715
02/25/2021 John D. Young
Group President
163,334   Derivative/Non-derivative trans. at $22.89 per share. 3,738,715
02/25/2021 Sally Susman
Executive Vice President
81,667   Derivative/Non-derivative trans. at $22.89 per share. 1,869,357
02/25/2021 Albert Bourla
Chairman & CEO; Director
163,334   Derivative/Non-derivative trans. at $22.86 per share. 3,733,815
02/25/2021 Douglas M. Lankler
Executive Vice President
99,816   Derivative/Non-derivative trans. at $22.89 per share. 2,284,788
02/25/2021 Rady A. Johnson
Executive Vice President
37,658   Derivative/Non-derivative trans. at $22.89 per share. 861,991
02/25/2021 Angela Hwang
Group President
22,686   Derivative/Non-derivative trans. at $22.89 per share. 519,282
02/25/2021 William R. Carapezzi
Executive Vice President
27,222   Derivative/Non-derivative trans. at $22.89 per share. 623,111
02/25/2021 Payal Sahni
Executive Vice President
9,982   Derivative/Non-derivative trans. at $22.89 per share. 228,487
02/25/2021 Jennifer B. Damico
SVP & Controller
12,477   Derivative/Non-derivative trans. at $22.89 per share. 285,598
02/25/2021 Alexander Roderick MacKenzie
Executive Vice President
26,732   Award at $0 per share. 0
02/25/2021 Jennifer B. Damico
SVP & Controller
3,649   Award at $0 per share. 0
02/22/2021 William R. Carapezzi
Executive Vice President
1,410   Derivative/Non-derivative trans. at $34.26 per share. 48,306
02/22/2021 Payal Sahni
Executive Vice President
1,172   Derivative/Non-derivative trans. at $34.26 per share. 40,152
02/22/2021 Jennifer B. Damico
SVP & Controller
884   Derivative/Non-derivative trans. at $34.26 per share. 30,285
01/31/2021 Lidia L. Fonseca
Executive Vice President
6,749   Derivative/Non-derivative trans. at $35.9 per share. 242,289
12/29/2020 John D. Young
Group President
10,607   Derivative/Non-derivative trans. at $37.05 per share. 392,989
12/16/2020 Rady A. Johnson
Executive Vice President
661   Gift at $0 per share. 0
12/16/2020 Angela Hwang
Group President
12,970   490,784
11/09/2020 Sally Susman
Executive Vice President
43,662   Disposition at $41.94 per share. 1,831,184
11/09/2020 Albert Bourla
Chairman & CEO; Director
132,508   Disposition at $41.94 per share. 5,557,385
08/06/2020 Ronald E. Blaylock
Director
1,000   Acquisition at $38.62 per share. 38,620
08/06/2020 Ronald E. Blaylock
Director
1,000   Acquisition at $38.69 per share. 38,690
08/06/2020 Ronald E. Blaylock
Director
1,500   Acquisition at $38.51 per share. 57,765
08/06/2020 Ronald E. Blaylock
Director
2,500   Acquisition at $38.56 per share. 96,400
08/06/2020 Ronald E. Blaylock
Director
3,000   Acquisition at $38.55 per share. 115,650
08/06/2020 Ronald E. Blaylock
Director
4,000   Acquisition at $38.49 per share. 153,960
06/05/2020 Jennifer B. Damico
SVP & Controller
2,181   Disposition at $36.13 per share. 78,799
05/18/2020 Mikael Dolsten
President R&D
24,242   Disposition at $37.79 per share. 916,105
05/18/2020 Mikael Dolsten
President R&D
17,357   Disposition at $37.78 per share. 655,747
05/18/2020 Mikael Dolsten
President R&D
16,840   Disposition at $37.8 per share. 636,552
05/18/2020 Mikael Dolsten
President R&D
14,727   Disposition at $37.77 per share. 556,238
05/18/2020 Mikael Dolsten
President R&D
9,700   Disposition at $37.75 per share. 366,175
05/18/2020 Mikael Dolsten
President R&D
6,470   Disposition at $37.81 per share. 244,630
05/18/2020 Mikael Dolsten
President R&D
5,517   Disposition at $37.76 per share. 208,321
05/18/2020 Mikael Dolsten
President R&D
500   Disposition at $37.82 per share. 18,910

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
22 Purchases
47 Sales
1,370,189
1,191,316
Last 6 months
23 Purchases
52 Sales
1,383,159
1,385,503
Last 12 months
29 Purchases
61 Sales
1,396,159
1,483,037

Officers and Executives

Dr. Albert Bourla
Chairman, Chief Executive & Operating Officer
Mr. Frank A. D'Amelio
Chief Financial Officer & EVP-Global Supply
Dr. Aida Habtezion
Chief Medical Officer
Dr. Mikael Dolsten
Chief Scientific Officer & Research President
Ms. Lidia L. Fonseca
Executive VP, Chief Digital & Technology Officer
Dr. Monika A. Vnuk
Vice President-Worldwide Business Development
Dr. Hakan Sakul
Vice President & Head-Diagnostics
Ms. Deborah Baron
Senior VP-Worldwide Business Development
Dr. Barbara J. Dalton
Vice President-Worldwide Business Development
Ms. Sally Susman
Chief Corporate Affairs Officer & Executive VP
Mr. Douglas Ernest Giordano
Senior VP-Worldwide Business Development
Mr. Rady A. Johnson
Executive VP, Chief Compliance & Risk Officer
Dr. Alexander Roderick MacKenzie
Chief Development Officer & Executive VP
Mr. John D. Young
Chief Business Officer
Ms. Angela Hwang
Group President-Biopharmaceuticals
Mr. Andy Schmeltz
President-US Oncology Business Unit
Dr. Tamas Koncz
Senior Medical Director
Mr. John DeYoung
Vice President-Worldwide Business Development
Dr. Susan D. Desmond-Hellmann
Director
Ms. Jennifer B. Damico
Senior VP-Controller & Accounting Officer
Mr. Gordon Loh
Senior Vice President-Corporate Audit
Mr. Bryan Dunn
Investor Relations Contact
Ms. Payal Sahni Becher
Chief Human Resources Officer & Executive VP
Ms. Margaret M. Madden
Secretary, Chief Governance Counsel & Senior VP
Mr. Douglas M. Lankler
Executive Vice President & General Counsel
Dr. Scott Gottlieb
Independent Director
Ms. Suzanne Nora Johnson
Independent Director
Mr. James Quincey
Independent Director
Dr. Susan J. Hockfield
Independent Director
Dr. Helen H. Hobbs
Independent Director
Mr. Shantanu Narayen
Lead Independent Director
Mr. James C. Smith
Independent Director
Mr. Joseph J. Echevarria
Independent Director
Mr. Ronald E. Blaylock
Independent Director
Dr. Dan R. Littman
Independent Director
Link to MarketWatch's Slice.